National
Pharmaceutical investment of 21 billion pesos promotes Plan México
Pharmaceutical companies allocate 21 billion pesos for production and export in Mexico.
Pharmaceutical companies allocate 21 billion pesos for production and export in Mexico.
21 billion pesos to manufacture medicines in Mexico: the details of the plan announced by Sheinbaum.
Sheinbaum details investments by Abbott, Liomont, Sanofi and other firms to produce medicines in Mexico.
The president celebrates a rain of millions in medicines, while Michoacán becomes the new national laboratory.
A legislative proposal seeks to reverse dependence on medical imports and reactivate national production with clear demands on pharmaceutical companies.